Factor XIa Inhibitor Encouraging in Phase 2 MI, Stroke Studies ...Middle East

Medscape - News
It's all exploratory, but asundexian given with antiplatelets showed safe nuanced potential against poststroke recurrent events and quashed circulating factor XIa after stenting for acute MI. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Factor XIa Inhibitor Encouraging in Phase 2 MI, Stroke Studies )

Apple Storegoogle play

Also on site :